The authors evaluated maintenance of achieved cardiovascular risk control after discharge from a pharmacist-coordinated cardiovascular risk reduction clinic. Using data from 2001 to 2004 divided by financial quarters (ie, 3-month periods), the authors performed survival analysis of diabetic patients who had attained at least one cardiovascular risk goal in the clinic. Mean times to failure were 7.1±0.21 quarters for hemoglobin A1c, 7.6±0.29 quarters for low-density lipoprotein cholesterol (LDL-C), and 2.5±0.24 quarters for systolic blood pressure (SBP). Body mass index predicted glycemic control failure (hazard ratio [HR], 1.08; 95% confidence interval [CI], 1.01-1.15; P=.02), insulin use predicted LDL-C control failure (HR, 3.08; 95% CI, 1...
Diabetes is associated with a marked increase in the risk of cardiovascular disease. Epidemiological...
OBJECTIVE—To determine whether nurse case management with a therapeutic algorithm could effectively ...
Cardiovascular disease (CVD) is a major cause of morbidity and mor-tality among subjects who have di...
Background The atherogenic milieu of hypertension,hyperglycaemia and dyslipidaemia results in anexce...
OBJECTIVE — To describe the extent to which hyperglycemia, hypertension, and dyslipi-demia are curre...
Treatment of type 2 diabetes requires control of hyperglycemia, hyperlipidemia, and close monitoring...
Aims: To document in recent cohorts the degree of control of major cardiovascular (CV) risk factors ...
The Cardiovascular Risk Reduction Clinic (CRRC) is a pharmacist-coordinated care model that incorpor...
Clinical pharmacist interventions have resulted in optimized diabetes control in complex patients; h...
Purpose To assess whether VA MEDIC-E (Veterans Affairs Multi-disciplinary Education and Diabetes Int...
Background and Aims: The adverse cardiovascular disease (CVD) outcomes in diabetes mellitus can larg...
Cardiovascular disease is the leading complication of type 2 diabetes and approximately half of the ...
Objective: Evidence suggests diabetes mellitus is an independent risk factor for adverse cardiovasc...
Background and objective A Pharmacist-led Diabetes Cardiovascular Risk (DCVR) reduction clinic is es...
Purpose: Determine the prevalence of cardiovascular risk factors and to examine the influence of pa...
Diabetes is associated with a marked increase in the risk of cardiovascular disease. Epidemiological...
OBJECTIVE—To determine whether nurse case management with a therapeutic algorithm could effectively ...
Cardiovascular disease (CVD) is a major cause of morbidity and mor-tality among subjects who have di...
Background The atherogenic milieu of hypertension,hyperglycaemia and dyslipidaemia results in anexce...
OBJECTIVE — To describe the extent to which hyperglycemia, hypertension, and dyslipi-demia are curre...
Treatment of type 2 diabetes requires control of hyperglycemia, hyperlipidemia, and close monitoring...
Aims: To document in recent cohorts the degree of control of major cardiovascular (CV) risk factors ...
The Cardiovascular Risk Reduction Clinic (CRRC) is a pharmacist-coordinated care model that incorpor...
Clinical pharmacist interventions have resulted in optimized diabetes control in complex patients; h...
Purpose To assess whether VA MEDIC-E (Veterans Affairs Multi-disciplinary Education and Diabetes Int...
Background and Aims: The adverse cardiovascular disease (CVD) outcomes in diabetes mellitus can larg...
Cardiovascular disease is the leading complication of type 2 diabetes and approximately half of the ...
Objective: Evidence suggests diabetes mellitus is an independent risk factor for adverse cardiovasc...
Background and objective A Pharmacist-led Diabetes Cardiovascular Risk (DCVR) reduction clinic is es...
Purpose: Determine the prevalence of cardiovascular risk factors and to examine the influence of pa...
Diabetes is associated with a marked increase in the risk of cardiovascular disease. Epidemiological...
OBJECTIVE—To determine whether nurse case management with a therapeutic algorithm could effectively ...
Cardiovascular disease (CVD) is a major cause of morbidity and mor-tality among subjects who have di...